We demonstrated that overexpression of PGRMC1 in MCF7 breast cancer cells (MCF7/PGRMC1) results in increased proliferation upon progestin treatment, as compared to empty vector control cells (MCF7/EVC) [36–38, 44–47]. The gene discussed is PGRMC1; the disease is breast carcinoma.